News Posts List
Cell find may aid cancer vaccines
11/05/2010
A type of normal cell often found in cancerous growths may be the reason for the failure of anti-cancer vaccines.
US drug distributor inks two billion dollar cancer deal
11/02/2010
McKesson will buy all outstanding shares of US Oncology for cash and assume its debt.
Glowing jellyfish can diagnose cancer
11/02/2010
Scientists say luminous cells from jellyfish can be used to diagnose cancers deep inside the body.
Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas
11/02/2010
The aim of this study was to identify genes associated with the tumor progression.
Clear Cell Tubulopapillary Renal Cell Carcinoma
10/30/2010
Recently several lowgrade renal cell tumors, distinct from those recognized by the 2004 World Health Organization classification of renal tumors, have been described.
Cancer Drugs Fund Offers Long-Term Hope To Kidney Cancer Patients
10/29/2010
Andrew Lansley's announcement that cancer patients in England will benefit from a £600 million fund to improve access to cancer drugs over the next three years has been welcomed by the James Whale Fund for Kidney Cancer.
Nicholas J. Vogelzang, MD, Receives Award From the Kidney Cancer Association
10/29/2010
Medical oncologist and cancer researcher Nicholas J. Vogelzang, MD, has been awarded the prestigious Eugene P. Schonfeld Award from the Kidney Cancer Association (KCA).
SGN-75 for the treatment of renal cancer
10/26/2010
At ESMO, Seattle Genetics gave investors another reason for optimism, this time following positive data for another wholly owned agent, SGN-75.
New cancer targets emerge from VHL study
10/26/2010
Inactivation of the von Hippel-Lindau tumor suppressor protein (pVHL) causes the most common form of kidney cancer. pVHL is part of a complex that polyubiquitinates the alpha subunit of the heterodimeric transcription factor HIF.
In Medicare's Data Trove, Clues to Curing Cost Crisis
10/26/2010
". . . the American public is barred from examining in detail how Medicare spends roughly . . .$62.5 billion . . ."